MyHeartPass™

Your complete Heart Assessment is designed to take you from “I should check my heart health” to actually knowing where you stand and what comes next.

• Home Blood Collection: Required cardiovascular and cardiometabolic markers, collected conveniently at home.
• Personalized Heart Assessment: Your clinical information and laboratory results come together to create a personalized view of your cardiovascular risk.
• Cardiologist Consultation: A cardiologist reviews your completed assessment with you, helps you understand what matters, and discusses the appropriate next steps.
• Lifetime MyHeartPass: Your assessment becomes part of your personal electronic health record giving you continued access to your health information as your prevention journey evolves.

One journey. From understanding your risk to knowing what to do next.

MyHeartPass is your personal electronic health record within AnginaX, designed to maintain your health information securely and longitudinally over time. It extends beyond your Heart Assessment. MyHeartPass provides a unified place for your available medical records, AnginaX assessments, laboratory reports and other health information, allowing your medical history to remain accessible across assessments and episodes of care.

MyHeartPass is designed around continuity, individual access and privacy so that your health information can remain with you as your healthcare journey evolves. Personal and health information within MyHeartPass is processed and protected in accordance with applicable data-protection requirements, including India’s Digital Personal Data Protection framework, and the consent choices applicable to the services you use.

Your health record. With you over time.

Yes. AnginaX is designed to support clinical care, not restrict where that care occurs. Your assessment and available reports can be accessed through MyHeartPass and shared with your own physician or another qualified healthcare professional for independent review and continued care.

No. AnginaX is designed for cardiovascular prevention and structured risk assessment. It is not an emergency medical service. Symptoms such as significant or persistent chest pain or pressure, severe difficulty breathing, loss of consciousness, or other symptoms suggesting a medical emergency require immediate medical attention through appropriate emergency medical services. Do not delay emergency medical care in order to complete an AnginaX assessment.

AnginaX is designed with privacy, security and controlled access to health information as core infrastructure requirements. Personal and health information is collected and processed only for defined and lawful purposes, including providing the healthcare services requested by you, maintaining your health records, coordinating authorized care, and securely operating the AnginaX platform.

Access to health information is restricted to authorized personnel, healthcare professionals and service providers where access is necessary to provide the requested services, fulfill applicable legal obligations, or where otherwise permitted by law. AnginaX applies appropriate technical, organizational and access-control safeguards to protect personal and health information against unauthorized access, use, disclosure, alteration or loss.

The processing of personal data is governed by applicable Indian data-protection requirements, including the Digital Personal Data Protection Act, 2023 and rules in force thereunder, together with the consent and privacy choices applicable to the services you use.

You can learn more about what information AnginaX collects, why it is processed, how it may be shared or retained, and your available rights and choices in the AnginaX Privacy Notice and Patient Consent.

Your health information remains your information. AnginaX processes your personal and health information only for defined and lawful purposes associated with the services you request, the delivery and continuity of your care, maintenance of your health records, and secure operation of the AnginaX platform. Your information is not made available without purpose.

Access is limited to authorized personnel, healthcare professionals, diagnostic partners and service providers where necessary to provide requested services, meet applicable legal obligations, or where otherwise permitted by law.

You retain the rights and choices available to you under applicable data-protection law, including rights relating to access to information about processing, correction and updating of personal data, grievance redressal, and withdrawal of consent where processing is based on consent. Certain information may need to be retained where required or permitted by applicable healthcare, regulatory, legal or record-keeping obligations.

AnginaX is designed around the principle that health information should remain connected to the individual, accessible through appropriate safeguards, and used responsibly for the purposes for which it was provided. Full details regarding data processing, consent, retention, sharing, your rights and how to exercise them are available in the AnginaX Privacy Notice and Patient Consent.

Cardiovascular prevention is the systematic identification and management of factors that contribute to future cardiovascular disease. It extends beyond detecting an existing condition. Prevention considers multiple dimensions of cardiovascular health including clinical history, blood pressure, metabolic health, lipid-related markers, lifestyle factors, family history and other relevant clinical information to help healthcare professionals understand risk and determine appropriate preventive pathways.

The objective is not simply to estimate risk, but to identify modifiable factors early, support appropriate clinical action, and reassess cardiovascular health over time.

Cardiovascular disease is multifactorial. No single laboratory value, symptom or measurement provides a complete representation of an individual’s cardiovascular risk. Clinical risk assessment therefore considers multiple variables together.

Depending on the individual and clinical context, these may include age, sex, blood pressure, glycemic health, cholesterol-related markers, kidney health, family history, lifestyle and other clinically relevant factors. AnginaX is designed around this multidimensional approach rather than interpreting cardiovascular health through an isolated test result.

Yes. Many important cardiovascular and cardiometabolic risk factors can develop without noticeable symptoms. These may include elevated blood pressure, atherogenic lipid exposure, impaired glycemic and metabolic health, inflammation, kidney-related risk factors, and inherited predisposition.

Importantly, cardiovascular risk is influenced not only by a measurement taken today, but also by biological exposure over time. Prolonged exposure to atherogenic lipoproteins, elevated blood pressure, impaired glycemic health and other risk factors may contribute to cumulative cardiovascular burden even while a person feels well.

This is why preventive cardiovascular care should not end with identifying risk. The goal is to identify relevant risk early, address modifiable contributors through appropriate preventive care, reassess whether risk is moving in the desired direction, and support that progress over time. AnginaX is designed around this longitudinal approach helping move prevention from a one-time risk estimate toward continuous risk governance across the individual’s cardiovascular journey.

Having cardiovascular risk does not mean that cardiovascular disease is necessarily present or that a cardiovascular event will occur.

Screening generally provides information at a particular point in time. Prevention is broader. It may involve risk assessment, appropriate diagnostic testing, clinical interpretation, management of modifiable risk factors, physician-guided intervention where appropriate, follow-up and reassessment.

AnginaX is designed around this longitudinal principle: Assessment is a point in time. Prevention is a pathway over time.

AnginaX brings together relevant clinical information within a structured, multidimensional cardiovascular risk-assessment framework. Depending on the assessment pathway, this may include medical and family history, lifestyle information, vital parameters, anthropometric measurements and relevant laboratory markers.

These inputs are evaluated through AnginaX’s clinical decision-support infrastructure to support structured risk assessment and personalized preventive pathways for review by qualified healthcare professionals. The purpose is not to interpret a single marker or produce an isolated number, but to develop a more clinically meaningful view of cardiovascular risk.

No. Risk estimation answers an important question: What does my cardiovascular risk look like at this point in time?

Prevention requires additional questions: What factors are contributing to that risk? What should be reviewed or addressed? When should it be reassessed? And over time, is the individual’s cardiovascular risk profile moving in the desired direction?

AnginaX is designed around this broader concept of risk governance connecting assessment with clinical review, preventive pathways, appropriate follow-up and longitudinal reassessment. The objective is to make cardiovascular risk not only measurable, but understandable, clinically actionable and capable of being followed over time.

Risk governance is the principle that identifying cardiovascular risk should not be the end of the prevention process. An assessment represents an individual’s cardiovascular state using the information available at that time.

As new clinical information becomes available such as changes in blood pressure, laboratory markers, metabolic health, lifestyle or treatment the individual’s cardiovascular profile may also change. Risk governance provides a structured framework for assessment, clinical interpretation, appropriate action, reassessment and follow-up over time, with healthcare professionals retaining responsibility for clinical decisions.

In simple terms, prevention should not only ask: “What is my risk?” It should also ask: “How is my cardiovascular health changing over time?”

Cardiovascular biology changes over time. Blood pressure, lipid levels, glycemic health, weight, kidney function, lifestyle, medication use and other factors may improve, worsen or remain stable. Some cardiovascular exposures are also cumulative, meaning that duration of exposure can matter alongside the measurement itself.

A single assessment cannot fully represent that evolving history. For this reason, AnginaX is designed to support a longitudinal cardiovascular record in which assessments and relevant clinical information can be considered over time. The trajectory not simply the individual score is an important part of prevention.

Because cardiovascular risk is dynamic. New laboratory results, changes in blood pressure, metabolic health, lifestyle, medications, age and other clinical information may change how an individual’s cardiovascular health is understood.

A change in an assessment does not necessarily mean that an earlier assessment was incorrect. It may reflect new information or a genuine change in the individual’s cardiovascular state. This is why AnginaX treats an assessment as part of a longitudinal record rather than a permanent verdict.

Laboratory markers provide objective information about biological processes associated with cardiovascular and cardiometabolic health. Depending on the assessment pathway, laboratory information may contribute to understanding lipid-related risk, glycemic health, inflammation, renal function and other clinically relevant dimensions.

These results are considered alongside other relevant clinical information. A laboratory value by itself is not treated as a diagnosis or as a complete representation of cardiovascular risk.

Personalized does not mean that every individual receives a different medical standard. It means that relevant clinical information is considered in the context of the individual rather than applying the same interpretation to everyone.

Factors such as age, sex, family history, existing risk factors, clinical measurements, laboratory findings and lifestyle may influence an individual’s cardiovascular risk profile and the preventive considerations relevant to that person. Clinical decisions remain subject to the judgment of qualified healthcare professionals.

Responsible Clinical AI is the application of artificial intelligence within a framework of human oversight, clinical accountability, transparency, safety and appropriate governance. At AnginaX, AI is not intended to operate as an autonomous medical authority. It is used to help structure complex health information, support cardiovascular risk assessment, identify clinically relevant patterns and assist healthcare professionals in evaluating preventive pathways.

Qualified healthcare professionals retain authority over medical judgment, diagnosis, treatment and prescribing. AI-generated insights are therefore designed to inform clinical decisions.

Responsible Clinical AI also requires more than human oversight. It requires that clinical AI be evidence-led, appropriately validated, monitored over time, transparent about its limitations, and governed as the science, data and clinical environment evolve.

For AnginaX, responsible AI is ultimately a principle of trust: Technology should strengthen clinical intelligence while human judgment, accountability and patient interest remain at the center of care.

Clinical AI means that technology is used to support appropriate clinical judgment. Within AnginaX, clinical AI and intelligent technology help organize relevant health information, support structured cardiovascular risk assessment, identify clinically relevant patterns and assist healthcare professionals in preventive decision-making. Clinical responsibility remains with qualified healthcare professionals where medical judgment, diagnosis, treatment or prescribing is required.

Cardiovascular risk does not necessarily remain the same throughout life. Clinical measurements, metabolic health, lifestyle, medications and other factors can change. Preventive interventions may also alter an individual’s risk-factor profile.

For this reason, AnginaX is designed to support reassessment and continuity rather than treating prevention as a one-time health check. The scientific principle is that risk can be estimated at a moment. Prevention must be managed over time.

Yes. Some cardiovascular risk factors cannot be modified, including age and certain inherited characteristics. Others including blood pressure, atherogenic lipid exposure, glycemic and metabolic health, tobacco exposure, physical activity and other cardiometabolic factors may change or be clinically managed.

Importantly, cardiovascular risk reflects not only the level of a risk factor at a single point in time, but also its duration, cumulative exposure and trajectory over time. For example, prolonged exposure to atherogenic lipoproteins, elevated blood pressure or impaired glycemic health may contribute to cardiovascular burden even when an individual has no symptoms.

The purpose of longitudinal prevention is therefore not simply to assign a risk category. It is to understand the factors contributing to risk, support appropriate preventive action, reassess them over time, and determine whether the individual’s cardiovascular risk profile is moving toward and being maintained at a more favorable state.

Lower estimated risk does not mean zero risk, just as higher estimated risk does not mean that a cardiovascular event will necessarily occur. Risk assessment represents probability based on the information available at that time.

It should therefore be understood as a clinical state to be interpreted in context not as a permanent label or prediction of an individual’s future.

The appropriate next step depends on the individual’s findings and clinical context. This may involve physician review, lifestyle intervention, management of relevant risk factors, further investigation, medication considerations where clinically appropriate, or earlier follow-up and reassessment.

AnginaX supports structured preventive pathways while preserving clinical decision-making with qualified healthcare professionals.

The infrastructure is intended to support cardiovascular prevention across both individual care and population health. The individual Assessment Platform is one access point into the broader AnginaX cardiovascular prevention infrastructure.

AnginaX is designed to support prevention across physicians, hospitals and health systems, diagnostic laboratories, public health and government programs, insurers, community health organizations, and academic and research settings.

AnginaX is built around a fundamental principle i.e. Prevention should not be an isolated health check. It should be a continuous, measurable and clinically connected part of healthcare.

AnginaX brings together medical science, structured risk assessment, preventive pathways, Responsible Clinical AI, longitudinal health information and healthcare professionals to support prevention that is accessible to individuals, actionable for clinicians, measurable for institutions and scalable across populations.